Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FIDAXOMICIN 200 MG TABLET

Fidaxomicin
$158.6580per EA

Strength

200 mg/1

Manufacturer

Apotex Corp.

NDC

60505483302

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

FIDAXOMICIN

Approval Type

Generic (ANDA)

FDA Application

ANDA219559

On Market Since

2/2/2026

Pharmacological Classes

Macrolide Antibacterial
Macrolides

Price History

1W

0.0%

1M

-18.1%

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-17.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

AZITHROMYCIN 200 MG/5 ML SUSP
Generic
00093202631•Teva Pharmaceuticals USA Inc.
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
24658070834•PuraCap Laboratories LLC
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
42806015134•Epic Pharma LLC
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
59651000830•Aurobindo Pharma Limited
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
62135070543•Chartwell RX LLC
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
70436022236•Slate Run Pharmaceuticals LLC
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
70710146002•Zydus Pharmaceuticals (USA) Inc.
$0.2159
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
00093202694•Teva Pharmaceuticals USA Inc.
$0.2279
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
24658070733•PuraCap Laboratories LLC
$0.2279
per ML
AZITHROMYCIN 200 MG/5 ML SUSP
Generic
42806015033•Epic Pharma LLC
$0.2279
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy